Judy Garber

Dana-Farber Cancer Institute & Harvard Medical School, Massachusetts, USA

Dr Garber is the Susan F. Smith Chair and Chief of the Division of Cancer Genetics and Prevention at Dana-Farber Cancer Institute and a Professor of Medicine at Harvard Medical School. She conducts research in clinical cancer genetics, with a special focus in the genetics of breast cancer. Dr Garber is also a leader in research into the characteristics and treatment of triple negative breast cancer, the most common form in women with BRCA1 mutations and an expert in Li-Fraumeni Syndrome. Her translational research focuses on the evaluation of novel agents targeting DNA repair defects in breast cancer, including PARP inhibitors for treatment and prevention of breast cancer and other BRCA-associated cancers, and the study of other agents for reduction of breast cancer risk.

Dr Garber is a past president of the American Association for Cancer Research (AACR). She served on the National Cancer Advisory Board of the National Cancer Institute and was elected into the American Society of Clinical Investigation, the American Association of Physicians and the National Academy of Medicine. She serves as the Scientific Director of the Breast Cancer Research Foundation and is a past chair of the Breast Cancer Research Foundation Scientific Advisory Board. She is an ASCO Statesman and a Fellow of the AACR Academy, and was its first president.

Cridlan Lecture: Genetics update

Presentation overview to follow

UKIBCS

Please contact the conference secretariat:
t: 01332 227776
e: ukibcs@kc-jones.co.uk